Survival analysis of patients with rare tumors of the uterine corpus – carcinosarcoma
Open Access
- 1 January 2024
- journal article
- research article
- Published by National Library of Serbia in Vojnosanitetski Pregled
- Vol. 81 (1) , 27-33
Abstract
Background/Aim. Uterine carcinosarcoma (UCS), formerly known as malignant mixed M?llerian tumor, is a rare, aggressive malignancy of the female genital tract. The aim of this study was to analyze the most important clinical and pathohistological characteristics of UCSs on operated patients, as well as to determine which of those factors are affecting progression-free survival (PFS) and overall survival (OS) of patients. Methods. The study was conducted as a retrospective analysis of medical data documentation of patients with a diagnosis of UCS who were surgically treated at the Department of Gynecology, Clinic for Operative Oncology, Oncology Institute of Vojvodina, Sremska Kamenica, Serbia, in 10 years? period (from the beginning of 2009 to the end of 2018). The analysis included data for a total of 31 patients. Results. Of all the examined parameters (age of the patient, clinical stage of the disease, histological grade, depth of myometrial invasion, and lymphovascular invasion ? LVI), the greatest influence on the choice of therapeutic procedure had a histological tumor grade. Conclusion. Our research showed the joint influence of the examined clinical and pathohistological factors on PFS and OS of patients with UCS. The only independent parameter that showed a statistically significant impact on survival is LVI.Keywords
This publication has 36 references indexed in Scilit:
- Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcomaAnnals of Oncology, 2016
- Evaluation of brachytherapy and external beam radiation therapy for early stage, node-negative uterine carcinosarcomaBrachytherapy, 2015
- Uterine carcinosarcoma: A review of the literatureGynecologic Oncology, 2015
- Rare uterine cancer: Carcinosarcomas. Review from histology to treatmentCritical Reviews in Oncology/Hematology, 2015
- Uterine Carcinosarcomas (Malignant Mixed Müllerian Tumours): A Review with Special Emphasis on the Controversies in ManagementObstetrics and Gynecology International, 2011
- Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor componentLaboratory Investigation, 2011
- Uterine carcinosarcomas: 8-year single center experience of 25 casesIndian Journal of Medical and Paediatric Oncology, 2011
- The impact of multi-modal therapy on survival for uterine carcinosarcomasGynecologic Oncology, 2010
- Malignant mixed müllerian tumors of the uterus: Analysis of patterns of failure, prognostic factors, and treatment outcomeInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?Journal of Clinical Pathology, 2002